参考文献/References:
[1] Sabater L,Gaig C,Gelpi E,et al.A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to lgLON5: a case series, characterisation of the antigen, and post-mortem study[J].Lancet Neurol,2014,13(6):575-586.
[2] Gaig C,Graus F,Compta Y.Clinical manifestations of the anti-IgLON5 disease[J].Neurology,2017,88(18):1736.
[3] Sabater L,Planagumà J,Dalmau J,et al.Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome[J].Journal of Neuroinflammation,2016,13(1):226.
[4] Hashimoto T,Maekawa S,Miyata S.IgLON cell adhesion molecules regulate synaptogenesis in hippocampal neurons[J].Cell Biochem Funct,2010,27(7):496-498.
[5] Karagogeos D.Neural GPI-anchored cell adhesion molecules[J].Front Biosci,2003,8(1-3):S1304-S1320.
[6] Huijbers MG,Querol LA,Niks EH,et al.The expanding field of IgG4-mediated neurological autoimmune disorders[J].European Journal of Neurology,2015,22(8):1151-1161.
[7] Ng JK,Malotka J,Kawakami N,et al.Neurofascin as a target for autoantibodies in peripheral neuropathies[J].Neurology,2012,79(23):2241-2248.
[8] Leypoldt F,Armangue T,Dalmau J.Autoimmune encephalopathies[J].Ann N Y Acad Sci,2015,1338(1):94-114.
[9] 中华医学会神经病学分会.中国自身免疫性脑炎诊治专家共识[J].中华神经科杂志,2017,50(2):91-98.
[10] Gelpi E,Hoeftberger R,Graus F,et al.Neuropathological criteria of anti-IgLON5-related tauopathy[J].Acta Neuropathol,2016,132(4):531-543.
[11] Schröder JB,Melzer N,Ruck T,et al.Isolated dysphagia as initial sign of anti-IgLON5 syndrome[J].Neurol Neuroimmunol Neuroinflamm,2016,4(1):e302.
[12] Högl B, Heidbreder A, Santamaria J, et al. IgLON5 autoimmunity and abnormal behaviours during sleep[J].Lancet, 2015, 385(9977):1590.
[13] Brueggemann N,Wandinger KP,Gaig CA,et al.Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies[J].Movement Disorders,2016,31(5):762-764.
[14] Ren HT,Yang YM,Huang Y,et al.Chorea and parkinsonism associated with autoantibodies to IgLON5 and responsive to immunotherapy[J].J Neuroimmunol,2016,300(300):9-10.
[15] Zhang W,Niu N,Cui RX.Serial F-18-FDG PET/CT findings in a patient with IgLON5 encephalopathy[J].Clin Nucl Med,2016,41(10):787-788.
[16] Pilgrim TM,Wyss TR.Takotsubo cardiomyopathy or transient left ventricular apical allooning syndrome:a systematic review[J].Int J Cardiol,2008,10(2):283-292.
[17] Silber MH,Autoimmune sleep disorders[M].[S.l.]: Handbook of Clinical Neurology,2016: 317.
[18] Lai MZ,Huijbers MG,Lancaster E,et al.Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to Potassium channels: a case series[J].Lancet Neurol,2010,9(8):776-785.
[19] M OM,Petit-Pedrol M,Graus F,et al.Clinical spectrum and diagnostic value of antibodies against the Potassium Channel related protein complex[J].Neurologia,2015,30(5):295-301.
[20] 古祺,毛悦时.自身免疫性脑炎的新进展与新类型[J].中国临床医学,2015,22(6):832-836.
[21] Irani SR,Pettingill P,Kleopa KA,et al.M orvan syndrome:clinical and serological observations in 29cases[J].Ann Neurol,2012,72(2):241-245.